Welcome to Med BioGene

Med BioGene’s lead product under development is LungExpress Dx™, a test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patient’s tumour to provide information to assist in tailoring treatment for that specific patient.  LungExpress Dx™ is the first and only gene expression-based test for non-small-cell lung cancer shown to assist in determining a patient's benefit from chemotherapy and prognosis for survival.

Med BioGene expects to commercialize LungExpress Dx™ in the United States in the second half of 2009.

E-MAIL ALERTS
Subscribe to our e-mail news alerts
First Name:
Last Name:
E-mail:
Quick Facts
Download our facts sheet


Home|About Us|Careers|News|Contact

© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer